Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Online First
Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
other Versions
You are currently viewing an
earlier version
of this article (January 10, 2022).
View the most recent version of this article
PDF
Original research
Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study
Online download statistics by month:
Online download statistics by month: October 2021 to April 2024
Abstract
Full
Pdf
Oct 2021
752
740
117
Nov 2021
418
417
60
Dec 2021
599
597
460
Jan 2022
992
991
888
Feb 2022
1249
1251
1087
Mar 2022
169
169
32
Apr 2022
1072
1077
1040
May 2022
1637
1635
1519
Jun 2022
1209
1210
1079
Jul 2022
143
145
28
Aug 2022
87
85
29
Sep 2022
71
71
18
Oct 2022
68
66
18
Nov 2022
32
32
16
Dec 2022
46
45
8
Jan 2023
23
23
12
Feb 2023
73
71
17
Mar 2023
54
49
14
Apr 2023
29
29
12
May 2023
57
55
22
Jun 2023
34
33
12
Jul 2023
29
29
20
Aug 2023
31
28
6
Sep 2023
47
46
9
Oct 2023
46
45
13
Nov 2023
44
35
7
Dec 2023
55
51
12
Jan 2024
21
21
9
Feb 2024
60
56
12
Mar 2024
26
24
43
Apr 2024
23
23
10
Total
9196
9149
6629
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF